Addition Therapeutics Announces Multiple Oral and Poster Presentations at the American Society of Gene & Cell Therapy (ASGCT) 29th Annual Meeting
Summary
'Best of both modalities” approach combines the efficacy, safety and scalability of RNA therapeutics with the multi-year durability of gene therapiesPortfolio...
Description
'Best of both modalities” approach combines the efficacy, safety and scalability of RNA therapeutics with the multi-year durability of gene therapiesPortfolio...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source